Microalgae polysaccharides ameliorates obesity in association with modulation of lipid metabolism and gut microbiota in high-fat-diet fed C57BL/6 mice

Microalgae are emerging as a good source of natural nutraceuticals and medicines. This study aims at evaluating the anti-obesity effects of two microalgae polysaccharides (CPS from Chlorella pyrenoidosa and SPS from Spirulina platensis) in high-fat diet (HFD)-induced obese C57BL/6 mice, with β-gluca...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of biological macromolecules 2021-07, Vol.182, p.1371-1383
Hauptverfasser: Guo, Wei, Zhu, Suqin, Li, Shiyang, Feng, Yinong, Wu, Haohao, Zeng, Mingyong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1383
container_issue
container_start_page 1371
container_title International journal of biological macromolecules
container_volume 182
creator Guo, Wei
Zhu, Suqin
Li, Shiyang
Feng, Yinong
Wu, Haohao
Zeng, Mingyong
description Microalgae are emerging as a good source of natural nutraceuticals and medicines. This study aims at evaluating the anti-obesity effects of two microalgae polysaccharides (CPS from Chlorella pyrenoidosa and SPS from Spirulina platensis) in high-fat diet (HFD)-induced obese C57BL/6 mice, with β-glucan as a positive control polysaccharide. CPS, SPS and β-glucan were daily administered intragastrically during 10-week HFD feeding, and conferred equally effective protection against overweight, energy imbalance, glucose tolerance impairment, systemic inflammation, dyslipidemia, and fat deposition in the liver and epididymal white adipose tissues. By western blotting analysis of CPT-1, PPARγ and SREBP-1c, those polysaccharides increased lipolysis and decreased lipogenesis in the liver. According to high-throughput sequencing of fecal 16S rRNA, CPS, SPS and β-glucan corrected the HFD-induced gut dysbiosis similarly by increasing beneficial bacteria especially Clostridia, Bacterioidia and Mollicutes and decreasing unfavorable bacteria especially Actinobacteria and Verrucomicrobia and, as revealed by PICRUSt functional analysis, they restored the HFD-induced perturbations in many gut bacterial enzymes and pathways involved in the metabolism of SCFAs, secondary bile acids and trimethylamine, implicating a possible anti-obesity mechanism through gut microbiome-mediated modulation of host lipid metabolism. Microalgae polysaccharides can thus serve as potent alternative food ingredients to improve disease conditions in obese patients. [Display omitted] •High molecular weight heteropolysaccharides are obtained from Chlorella and Spirulina.•Chlorella and Spirulina polysaccharides attenuate high-fat-diet-induced mouse obesity.•Chlorella and Spirulina polysaccharides modulate hepatic lipolysis and lipogenesis.•Chlorella and Spirulina polysaccharides improve high-fat-diet-induced gut dysbiosis.
doi_str_mv 10.1016/j.ijbiomac.2021.05.067
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2528909703</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0141813021010424</els_id><sourcerecordid>2528909703</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-17c931019664994d06f5d6c21e1069cd750315511d5bb172a4dc44884b71fdda3</originalsourceid><addsrcrecordid>eNqFkU2P0zAQhi0EYsvCX1j5yCXZcRI78Q2olg-piAucLceetFMlcYldUP8IvxdH3eXKyR96Zl6PH8buBJQChLo_lnTsKUzWlRVUogRZgmqfsY3oWl0AQP2cbUA0ouhEDTfsVYzHfKuk6F6ym7oBaITWG_bnK7kl2HFvkZ_CeInWuYNdyGPkdsKRwmJT3oceI6ULp5nbGIMjmyjM_DelA5-CP4_Xcxj4SCfyfMJk-zBSnLidPd-fE5_WpPzmZNcuB9ofisGmwhMmPqDnW9l-2N2rlcPX7MVgx4hvHtdb9uPjw_ft52L37dOX7ftd4WrVpUK0Ttf5P7RSjdaNBzVIr1wlUIDSzrcSaiGlEF72vWgr23jXNF3X9K0YvLf1LXt77Xtaws8zxmQmig7H0c4YztFUsuo06BbqjKormqeIccHBnBaa7HIxAszqxBzNkxOzOjEgTXaSC-8eM879hP5f2ZOEDLy7Apgn_UW4mOgIZ4eeFnTJ-ED_y_gL8eaiGA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2528909703</pqid></control><display><type>article</type><title>Microalgae polysaccharides ameliorates obesity in association with modulation of lipid metabolism and gut microbiota in high-fat-diet fed C57BL/6 mice</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Guo, Wei ; Zhu, Suqin ; Li, Shiyang ; Feng, Yinong ; Wu, Haohao ; Zeng, Mingyong</creator><creatorcontrib>Guo, Wei ; Zhu, Suqin ; Li, Shiyang ; Feng, Yinong ; Wu, Haohao ; Zeng, Mingyong</creatorcontrib><description>Microalgae are emerging as a good source of natural nutraceuticals and medicines. This study aims at evaluating the anti-obesity effects of two microalgae polysaccharides (CPS from Chlorella pyrenoidosa and SPS from Spirulina platensis) in high-fat diet (HFD)-induced obese C57BL/6 mice, with β-glucan as a positive control polysaccharide. CPS, SPS and β-glucan were daily administered intragastrically during 10-week HFD feeding, and conferred equally effective protection against overweight, energy imbalance, glucose tolerance impairment, systemic inflammation, dyslipidemia, and fat deposition in the liver and epididymal white adipose tissues. By western blotting analysis of CPT-1, PPARγ and SREBP-1c, those polysaccharides increased lipolysis and decreased lipogenesis in the liver. According to high-throughput sequencing of fecal 16S rRNA, CPS, SPS and β-glucan corrected the HFD-induced gut dysbiosis similarly by increasing beneficial bacteria especially Clostridia, Bacterioidia and Mollicutes and decreasing unfavorable bacteria especially Actinobacteria and Verrucomicrobia and, as revealed by PICRUSt functional analysis, they restored the HFD-induced perturbations in many gut bacterial enzymes and pathways involved in the metabolism of SCFAs, secondary bile acids and trimethylamine, implicating a possible anti-obesity mechanism through gut microbiome-mediated modulation of host lipid metabolism. Microalgae polysaccharides can thus serve as potent alternative food ingredients to improve disease conditions in obese patients. [Display omitted] •High molecular weight heteropolysaccharides are obtained from Chlorella and Spirulina.•Chlorella and Spirulina polysaccharides attenuate high-fat-diet-induced mouse obesity.•Chlorella and Spirulina polysaccharides modulate hepatic lipolysis and lipogenesis.•Chlorella and Spirulina polysaccharides improve high-fat-diet-induced gut dysbiosis.</description><identifier>ISSN: 0141-8130</identifier><identifier>EISSN: 1879-0003</identifier><identifier>DOI: 10.1016/j.ijbiomac.2021.05.067</identifier><identifier>PMID: 34004199</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adipose Tissue, White - drug effects ; Adipose Tissue, White - pathology ; Administration, Oral ; Animals ; Bacteria - classification ; Bacteria - genetics ; Diet, High-Fat ; Dyslipidemias - complications ; Energy Metabolism - drug effects ; Gastrointestinal Microbiome - drug effects ; Glucose Tolerance Test ; Gut microbiota ; High-fat-diet ; Inflammation - pathology ; Lipid metabolism ; Lipid Metabolism - drug effects ; Liver - drug effects ; Liver - metabolism ; Liver - pathology ; Mice ; Mice, Inbred C57BL ; Mice, Obese ; Microalgae - chemistry ; Microalgae polysaccharides ; Monosaccharides - analysis ; Obesity ; Obesity - drug therapy ; Obesity - metabolism ; Obesity - microbiology ; Phylogeny ; Polysaccharides - administration &amp; dosage ; Polysaccharides - pharmacology ; Polysaccharides - therapeutic use</subject><ispartof>International journal of biological macromolecules, 2021-07, Vol.182, p.1371-1383</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-17c931019664994d06f5d6c21e1069cd750315511d5bb172a4dc44884b71fdda3</citedby><cites>FETCH-LOGICAL-c368t-17c931019664994d06f5d6c21e1069cd750315511d5bb172a4dc44884b71fdda3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijbiomac.2021.05.067$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3541,27915,27916,45986</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34004199$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Guo, Wei</creatorcontrib><creatorcontrib>Zhu, Suqin</creatorcontrib><creatorcontrib>Li, Shiyang</creatorcontrib><creatorcontrib>Feng, Yinong</creatorcontrib><creatorcontrib>Wu, Haohao</creatorcontrib><creatorcontrib>Zeng, Mingyong</creatorcontrib><title>Microalgae polysaccharides ameliorates obesity in association with modulation of lipid metabolism and gut microbiota in high-fat-diet fed C57BL/6 mice</title><title>International journal of biological macromolecules</title><addtitle>Int J Biol Macromol</addtitle><description>Microalgae are emerging as a good source of natural nutraceuticals and medicines. This study aims at evaluating the anti-obesity effects of two microalgae polysaccharides (CPS from Chlorella pyrenoidosa and SPS from Spirulina platensis) in high-fat diet (HFD)-induced obese C57BL/6 mice, with β-glucan as a positive control polysaccharide. CPS, SPS and β-glucan were daily administered intragastrically during 10-week HFD feeding, and conferred equally effective protection against overweight, energy imbalance, glucose tolerance impairment, systemic inflammation, dyslipidemia, and fat deposition in the liver and epididymal white adipose tissues. By western blotting analysis of CPT-1, PPARγ and SREBP-1c, those polysaccharides increased lipolysis and decreased lipogenesis in the liver. According to high-throughput sequencing of fecal 16S rRNA, CPS, SPS and β-glucan corrected the HFD-induced gut dysbiosis similarly by increasing beneficial bacteria especially Clostridia, Bacterioidia and Mollicutes and decreasing unfavorable bacteria especially Actinobacteria and Verrucomicrobia and, as revealed by PICRUSt functional analysis, they restored the HFD-induced perturbations in many gut bacterial enzymes and pathways involved in the metabolism of SCFAs, secondary bile acids and trimethylamine, implicating a possible anti-obesity mechanism through gut microbiome-mediated modulation of host lipid metabolism. Microalgae polysaccharides can thus serve as potent alternative food ingredients to improve disease conditions in obese patients. [Display omitted] •High molecular weight heteropolysaccharides are obtained from Chlorella and Spirulina.•Chlorella and Spirulina polysaccharides attenuate high-fat-diet-induced mouse obesity.•Chlorella and Spirulina polysaccharides modulate hepatic lipolysis and lipogenesis.•Chlorella and Spirulina polysaccharides improve high-fat-diet-induced gut dysbiosis.</description><subject>Adipose Tissue, White - drug effects</subject><subject>Adipose Tissue, White - pathology</subject><subject>Administration, Oral</subject><subject>Animals</subject><subject>Bacteria - classification</subject><subject>Bacteria - genetics</subject><subject>Diet, High-Fat</subject><subject>Dyslipidemias - complications</subject><subject>Energy Metabolism - drug effects</subject><subject>Gastrointestinal Microbiome - drug effects</subject><subject>Glucose Tolerance Test</subject><subject>Gut microbiota</subject><subject>High-fat-diet</subject><subject>Inflammation - pathology</subject><subject>Lipid metabolism</subject><subject>Lipid Metabolism - drug effects</subject><subject>Liver - drug effects</subject><subject>Liver - metabolism</subject><subject>Liver - pathology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Obese</subject><subject>Microalgae - chemistry</subject><subject>Microalgae polysaccharides</subject><subject>Monosaccharides - analysis</subject><subject>Obesity</subject><subject>Obesity - drug therapy</subject><subject>Obesity - metabolism</subject><subject>Obesity - microbiology</subject><subject>Phylogeny</subject><subject>Polysaccharides - administration &amp; dosage</subject><subject>Polysaccharides - pharmacology</subject><subject>Polysaccharides - therapeutic use</subject><issn>0141-8130</issn><issn>1879-0003</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU2P0zAQhi0EYsvCX1j5yCXZcRI78Q2olg-piAucLceetFMlcYldUP8IvxdH3eXKyR96Zl6PH8buBJQChLo_lnTsKUzWlRVUogRZgmqfsY3oWl0AQP2cbUA0ouhEDTfsVYzHfKuk6F6ym7oBaITWG_bnK7kl2HFvkZ_CeInWuYNdyGPkdsKRwmJT3oceI6ULp5nbGIMjmyjM_DelA5-CP4_Xcxj4SCfyfMJk-zBSnLidPd-fE5_WpPzmZNcuB9ofisGmwhMmPqDnW9l-2N2rlcPX7MVgx4hvHtdb9uPjw_ft52L37dOX7ftd4WrVpUK0Ttf5P7RSjdaNBzVIr1wlUIDSzrcSaiGlEF72vWgr23jXNF3X9K0YvLf1LXt77Xtaws8zxmQmig7H0c4YztFUsuo06BbqjKormqeIccHBnBaa7HIxAszqxBzNkxOzOjEgTXaSC-8eM879hP5f2ZOEDLy7Apgn_UW4mOgIZ4eeFnTJ-ED_y_gL8eaiGA</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Guo, Wei</creator><creator>Zhu, Suqin</creator><creator>Li, Shiyang</creator><creator>Feng, Yinong</creator><creator>Wu, Haohao</creator><creator>Zeng, Mingyong</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20210701</creationdate><title>Microalgae polysaccharides ameliorates obesity in association with modulation of lipid metabolism and gut microbiota in high-fat-diet fed C57BL/6 mice</title><author>Guo, Wei ; Zhu, Suqin ; Li, Shiyang ; Feng, Yinong ; Wu, Haohao ; Zeng, Mingyong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-17c931019664994d06f5d6c21e1069cd750315511d5bb172a4dc44884b71fdda3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adipose Tissue, White - drug effects</topic><topic>Adipose Tissue, White - pathology</topic><topic>Administration, Oral</topic><topic>Animals</topic><topic>Bacteria - classification</topic><topic>Bacteria - genetics</topic><topic>Diet, High-Fat</topic><topic>Dyslipidemias - complications</topic><topic>Energy Metabolism - drug effects</topic><topic>Gastrointestinal Microbiome - drug effects</topic><topic>Glucose Tolerance Test</topic><topic>Gut microbiota</topic><topic>High-fat-diet</topic><topic>Inflammation - pathology</topic><topic>Lipid metabolism</topic><topic>Lipid Metabolism - drug effects</topic><topic>Liver - drug effects</topic><topic>Liver - metabolism</topic><topic>Liver - pathology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Obese</topic><topic>Microalgae - chemistry</topic><topic>Microalgae polysaccharides</topic><topic>Monosaccharides - analysis</topic><topic>Obesity</topic><topic>Obesity - drug therapy</topic><topic>Obesity - metabolism</topic><topic>Obesity - microbiology</topic><topic>Phylogeny</topic><topic>Polysaccharides - administration &amp; dosage</topic><topic>Polysaccharides - pharmacology</topic><topic>Polysaccharides - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guo, Wei</creatorcontrib><creatorcontrib>Zhu, Suqin</creatorcontrib><creatorcontrib>Li, Shiyang</creatorcontrib><creatorcontrib>Feng, Yinong</creatorcontrib><creatorcontrib>Wu, Haohao</creatorcontrib><creatorcontrib>Zeng, Mingyong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of biological macromolecules</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guo, Wei</au><au>Zhu, Suqin</au><au>Li, Shiyang</au><au>Feng, Yinong</au><au>Wu, Haohao</au><au>Zeng, Mingyong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Microalgae polysaccharides ameliorates obesity in association with modulation of lipid metabolism and gut microbiota in high-fat-diet fed C57BL/6 mice</atitle><jtitle>International journal of biological macromolecules</jtitle><addtitle>Int J Biol Macromol</addtitle><date>2021-07-01</date><risdate>2021</risdate><volume>182</volume><spage>1371</spage><epage>1383</epage><pages>1371-1383</pages><issn>0141-8130</issn><eissn>1879-0003</eissn><abstract>Microalgae are emerging as a good source of natural nutraceuticals and medicines. This study aims at evaluating the anti-obesity effects of two microalgae polysaccharides (CPS from Chlorella pyrenoidosa and SPS from Spirulina platensis) in high-fat diet (HFD)-induced obese C57BL/6 mice, with β-glucan as a positive control polysaccharide. CPS, SPS and β-glucan were daily administered intragastrically during 10-week HFD feeding, and conferred equally effective protection against overweight, energy imbalance, glucose tolerance impairment, systemic inflammation, dyslipidemia, and fat deposition in the liver and epididymal white adipose tissues. By western blotting analysis of CPT-1, PPARγ and SREBP-1c, those polysaccharides increased lipolysis and decreased lipogenesis in the liver. According to high-throughput sequencing of fecal 16S rRNA, CPS, SPS and β-glucan corrected the HFD-induced gut dysbiosis similarly by increasing beneficial bacteria especially Clostridia, Bacterioidia and Mollicutes and decreasing unfavorable bacteria especially Actinobacteria and Verrucomicrobia and, as revealed by PICRUSt functional analysis, they restored the HFD-induced perturbations in many gut bacterial enzymes and pathways involved in the metabolism of SCFAs, secondary bile acids and trimethylamine, implicating a possible anti-obesity mechanism through gut microbiome-mediated modulation of host lipid metabolism. Microalgae polysaccharides can thus serve as potent alternative food ingredients to improve disease conditions in obese patients. [Display omitted] •High molecular weight heteropolysaccharides are obtained from Chlorella and Spirulina.•Chlorella and Spirulina polysaccharides attenuate high-fat-diet-induced mouse obesity.•Chlorella and Spirulina polysaccharides modulate hepatic lipolysis and lipogenesis.•Chlorella and Spirulina polysaccharides improve high-fat-diet-induced gut dysbiosis.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>34004199</pmid><doi>10.1016/j.ijbiomac.2021.05.067</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0141-8130
ispartof International journal of biological macromolecules, 2021-07, Vol.182, p.1371-1383
issn 0141-8130
1879-0003
language eng
recordid cdi_proquest_miscellaneous_2528909703
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adipose Tissue, White - drug effects
Adipose Tissue, White - pathology
Administration, Oral
Animals
Bacteria - classification
Bacteria - genetics
Diet, High-Fat
Dyslipidemias - complications
Energy Metabolism - drug effects
Gastrointestinal Microbiome - drug effects
Glucose Tolerance Test
Gut microbiota
High-fat-diet
Inflammation - pathology
Lipid metabolism
Lipid Metabolism - drug effects
Liver - drug effects
Liver - metabolism
Liver - pathology
Mice
Mice, Inbred C57BL
Mice, Obese
Microalgae - chemistry
Microalgae polysaccharides
Monosaccharides - analysis
Obesity
Obesity - drug therapy
Obesity - metabolism
Obesity - microbiology
Phylogeny
Polysaccharides - administration & dosage
Polysaccharides - pharmacology
Polysaccharides - therapeutic use
title Microalgae polysaccharides ameliorates obesity in association with modulation of lipid metabolism and gut microbiota in high-fat-diet fed C57BL/6 mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T01%3A27%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Microalgae%20polysaccharides%20ameliorates%20obesity%20in%20association%20with%20modulation%20of%20lipid%20metabolism%20and%20gut%20microbiota%20in%20high-fat-diet%20fed%20C57BL/6%20mice&rft.jtitle=International%20journal%20of%20biological%20macromolecules&rft.au=Guo,%20Wei&rft.date=2021-07-01&rft.volume=182&rft.spage=1371&rft.epage=1383&rft.pages=1371-1383&rft.issn=0141-8130&rft.eissn=1879-0003&rft_id=info:doi/10.1016/j.ijbiomac.2021.05.067&rft_dat=%3Cproquest_cross%3E2528909703%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2528909703&rft_id=info:pmid/34004199&rft_els_id=S0141813021010424&rfr_iscdi=true